Role of Estrogen in the Aetiology and Treatment of Mood Disorders

ISSN： 1172-7047

Source： CNS Drugs, Vol.15, Iss.10, 2001-01, pp. : 797-817

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mood and Anxiety Disorders in Patients with Myasthenia Gravis: Aetiology, Diagnosis and Treatment

By Isin Baral Kulaksizoglu

CNS Drugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 473-481

Adis International

Access to resources Recommend Favorite

Psychotic and Mood Disorders Associated with the Perimenopausal Period: Epidemiology, Aetiology and Management

By Robinson G.E.

CNS Drugs, Vol. 15, Iss. 3, 2001-01 ,pp. : 175-184

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of Mood Disorders and Treatment Discontinuation

By Lader Malcolm

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1657-1663

Adis International

Access to resources Recommend Favorite

Riluzole in the Treatment of Mood and Anxiety Disorders

By Pittenger Christopher Coric Vladimir Banasr Mounira

CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. : 761-786

Adis International

Access to resources Recommend Favorite

Role of melatonin in mood disorders and the antidepressant effects of agomelatine

By Srinivasan Venkataramanujam De Berardis Domenico Shillcutt Samuel D Brzezinski Amnon

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1503-1522

Informa Healthcare

Access to resources Recommend Favorite